Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Restructuring Costs (2020)

Historic Restructuring Costs for Ekso Bionics Holdings (EKSO) over the last 1 years, with Q2 2020 value amounting to $244000.0.

  • Ekso Bionics Holdings' Restructuring Costs changed N/A to $244000.0 in Q2 2020 from the same period last year, while for Jun 2021 it was $244000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $244000.0 for FY2020, which is N/A changed from last year.
  • Ekso Bionics Holdings' Restructuring Costs amounted to $244000.0 in Q2 2020.
  • Ekso Bionics Holdings' 5-year Restructuring Costs high stood at $244000.0 for Q2 2020, and its period low was $244000.0 during Q2 2020.